Matches in Wikidata for { <http://www.wikidata.org/entity/Q94934687> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q94934687 description "clinical trial" @default.
- Q94934687 description "ensayo clínico" @default.
- Q94934687 description "ensayu clínicu" @default.
- Q94934687 description "klinisch onderzoek" @default.
- Q94934687 description "клінічне випробування" @default.
- Q94934687 description "临床试验" @default.
- Q94934687 name "A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q94934687 name "A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q94934687 type Item @default.
- Q94934687 label "A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q94934687 label "A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q94934687 prefLabel "A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q94934687 prefLabel "A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)" @default.
- Q94934687 P1050 Q94934687-C796E092-E17D-4235-A15F-8ECBD5036650 @default.
- Q94934687 P1132 Q94934687-F5211313-AD44-4EF1-BC8D-BE10A1DC80F8 @default.
- Q94934687 P1476 Q94934687-184D3608-60E2-4A4A-89E9-CB5D55043BB3 @default.
- Q94934687 P2899 Q94934687-F7810DAB-DF93-43A6-9B05-492454865B57 @default.
- Q94934687 P3098 Q94934687-62766C8C-1D73-4152-9ED8-142EBAF6FF35 @default.
- Q94934687 P31 Q94934687-00508D37-0443-44EC-983D-77626FE8E6DC @default.
- Q94934687 P4844 Q94934687-8DD6528C-4666-4174-8369-85710B5EF69E @default.
- Q94934687 P4844 Q94934687-DB35FDD1-1746-4C81-A01D-9497E0F8FF00 @default.
- Q94934687 P4844 Q94934687-F84B4C9B-A33A-48A0-97DC-589CC72EE31E @default.
- Q94934687 P580 Q94934687-907A8622-5C19-44DC-867A-1E41BAA04EF7 @default.
- Q94934687 P582 Q94934687-5573CC66-AB2F-40D9-9E12-77444B336AE7 @default.
- Q94934687 P6099 Q94934687-464A83EA-05F8-428C-B9ED-F94FFF0C818F @default.
- Q94934687 P8005 Q94934687-E1E5F1E9-08CA-41E5-A72B-40B55B20E788 @default.
- Q94934687 P8363 Q94934687-599282B1-640A-4F49-A0B0-1FC3666C71CD @default.
- Q94934687 P921 Q94934687-19C3421B-36F0-40E2-8465-9F11AD00774F @default.
- Q94934687 P1050 Q467635 @default.
- Q94934687 P1132 "+135" @default.
- Q94934687 P1476 "A Phase 1 Open-label Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma" @default.
- Q94934687 P2899 "+18" @default.
- Q94934687 P3098 "NCT04392648" @default.
- Q94934687 P31 Q30612 @default.
- Q94934687 P4844 Q408524 @default.
- Q94934687 P4844 Q419319 @default.
- Q94934687 P4844 Q7227206 @default.
- Q94934687 P580 "2020-06-24T00:00:00Z" @default.
- Q94934687 P582 "2023-11-10T00:00:00Z" @default.
- Q94934687 P6099 Q5452194 @default.
- Q94934687 P8005 Q76649614 @default.
- Q94934687 P8363 Q78089383 @default.
- Q94934687 P921 Q701216 @default.